Want to join the conversation?
David Vargas of Raymond James probes about the strength in new orders in the ELA segment. $MLHR said the biggest growth seen was in Asia and it was broadbased throughout Asia. The company had good activity levels on Continental Europe. In the Middle East, $MLHR saw improvement toward the end of 1Q17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?